Xiao-Fang Yu

Xiao-Fang Yu

Auto-generated profile, based on publicly available information

Xiao-Fang Yu

Institute of Virology and AIDS Research, First Hospital of Jilin University, Changchun, Jilin, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JDJuan Du
Juan Du
BZBaisong Zheng
Baisong Zheng
WZWenwen Zheng
Wenwen Zheng
PLPeng Li
Peng Li
JKJian Kang
Jian Kang
XYXiao-Fang Yu
Xiao-Fang Yu
Enterovirus 68 (EVD68) causes respiratory illness, mostly in children. Despite a reported low-level of transmission, the occurrence of several recent outbreaks worldwide including the 2014 outbreak in North America has raised concerns regarding the pathogenesis and evolution of EVD68. To elucidate the phylogenetic features of EVD68 and possible causes for the 2014 outbreak, 216 EVD68 strain sequences were retrieved from Genbank, including 22 from the 2014 outbreak. Several geographic and genotypic origins were established for these 22 strains, 19 of which were classified as Clade B. Of these 19 strains, 17 exhibited subsequent clustering and variation in protein residues involved in host-receptor interaction and/or viral antigenicity. Approximately 18 inter-clade variations were detected in VP1, which led to the identification of a new Clade D in EVD68 strains. The classification of this new clade was also verified by the re-construction of a Neighbor-Joining tree during the phylogenetic analysis. In addition, our results indicate that members of Clade B containing highly specific alterations in VP1 protein residues were the foremost contributors to the 2014 outbreak in the US. Altered host-receptor interaction and/or host immune recognition may explain the evolution of EVD68 as well as the global emergence and ongoing adaptation of this virus.

26 February 2015 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
CZChun-Feng Zhu
Chun-Feng Zhu
WWWei Wei
Wei Wei
XPXin Peng
Xin Peng
YDYu-Hui Dong
Yu-Hui Dong
YGYong Gong
Yong Gong
XYXiao-Fang Yu
Xiao-Fang Yu

4 November 2014 in Protein & Cell
Verified
Journal Article
Open access
PDF file
JKJia Kong
Jia Kong
BXBo Xu
Bo Xu
WWWei Wei
Wei Wei
XWXin Wang
Xin Wang
WXWei Xie
Wei Xie
XYXiao-Fang Yu
Xiao-Fang Yu

15 July 2015 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
JCJunliang Chang
Junliang Chang
JLJingliang Li
Jingliang Li
XLXin Liu
Xin Liu
GLGuanchen Liu
Guanchen Liu
JYJiaxin Yang
Jiaxin Yang
XYXiao-Fang Yu
Xiao-Fang Yu
Circulating enterovirus 71 (EV-A71)-associated hand, foot, and mouth disease is on the rise in the Asian-Pacific region. Although animal models have been developed using mouse-adapted EV-A71 strains, mouse models using primary EV-A71 isolates are scarce. Lethal animal models with circulating EV-A71 infection would contribute to studies of pathogenesis as well as vaccine development and evaluation. In this study, we established a lethal mouse model using primary EV-A71 isolates from patients infected with serotypes that are currently circulating in humans. We also characterized the dose-dependent virulence and pathologic changes of circulating EV-A71 in this mouse model. Most importantly, we have established this mouse model as a suitable system for EV-A71 vaccine evaluation. An inactivated EV-A71 vaccine candidate offered complete protection from death induced by various circulating EV-A71 viruses to neonatal mice that were born to immunized female mice. The sera of the immunized dams and their pups showed higher neutralization titers against multiple circulating EV-A71 viruses. Thus, our newly established animal model using primary EV-A71 isolates is helpful for future studies on viral pathogenesis and vaccine and drug development.

1 January 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
BXBo Xu
Bo Xu
JKjia kong
jia kong
XWXin Wang
Xin Wang
WWWei Wei
Wei Wei
WXWei Xie
Wei Xie
XYXiao-Fang Yu
Xiao-Fang Yu

30 May 2015 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
JCJunliang Chang
Junliang Chang
JLJingliang Li
Jingliang Li
WWWei Wei
Wei Wei
XLXin Liu
Xin Liu
GLGuanchen Liu
Guanchen Liu
XYXiao-Fang Yu
Xiao-Fang Yu